(PG) Procter & Gamble - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7427181091
Stock: Shampoo, Razor, Toothpaste, Detergent, Diaper
Total Rating 43
Risk 89
Buy Signal -0.27
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.71% |
| Yield on Cost 5y | 3.71% |
| Yield CAGR 5y | 5.28% |
| Payout Consistency | 99.5% |
| Payout Ratio | 62.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 15.2% |
| Relative Tail Risk | 0.74% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.29 |
| Alpha | -8.82 |
| Character TTM | |
|---|---|
| Beta | 0.130 |
| Beta Downside | 0.154 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.14% |
| CAGR/Max DD | 0.36 |
Description: PG Procter & Gamble January 28, 2026
The Procter & Gamble Company (PG) is a global consumer-packaged-goods leader operating across five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. Its portfolio includes household names such as Head & Shoulders, Pantene, Gillette, Olay, Crest, Tide, Pampers, and Charmin, sold through a mix of mass-merchandisers, e-commerce platforms, drug stores, and direct-to-consumer channels.
In FY 2023, PG reported net sales of $80.2 billion, delivering 5 % organic growth despite a 3 % rise in input-cost inflation, and achieved an operating margin of 18.5 %. The dividend yield hovered around 2.4 %, and free cash flow exceeded $15 billion, underscoring strong cash generation in a sector that benefits from steady demand and a shift toward online grocery and subscription purchasing.
For a data-driven deep-dive into PG’s valuation dynamics, consider reviewing the analytics available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 16.47b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -1.96 > 1.0 |
| NWC/Revenue: -11.86% < 20% (prev -9.67%; Δ -2.19% < -1%) |
| CFO/TA 0.15 > 3% & CFO 19.07b > Net Income 16.47b |
| Net Debt (25.81b) to EBITDA (23.62b): 1.09 < 3 |
| Current Ratio: 0.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.42b) vs 12m ago -1.39% < -2% |
| Gross Margin: 50.68% > 18% (prev 0.51%; Δ 5017 % > 0.5%) |
| Asset Turnover: 68.23% > 50% (prev 68.78%; Δ -0.55% > 0%) |
| Interest Coverage Ratio: 39.02 > 6 (EBITDA TTM 23.62b / Interest Expense TTM 406.0m) |
Altman Z'' 5.55
| A: -0.08 (Total Current Assets 26.59b - Total Current Liabilities 36.70b) / Total Assets 127.29b |
| B: 1.05 (Retained Earnings 133.98b / Total Assets 127.29b) |
| C: 0.13 (EBIT TTM 15.84b / Avg Total Assets 124.96b) |
| D: 1.70 (Book Value of Equity 125.88b / Total Liabilities 73.97b) |
| Altman-Z'' Score: 5.55 = AAA |
Beneish M -3.04
| DSRI: 1.00 (Receivables 6.28b/6.23b, Revenue 85.26b/84.35b) |
| GMI: 1.01 (GM 50.68% / 51.34%) |
| AQI: 0.98 (AQ_t 0.60 / AQ_t-1 0.61) |
| SGI: 1.01 (Revenue 85.26b / 84.35b) |
| TATA: -0.02 (NI 16.47b - CFO 19.07b) / TA 127.29b) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of PG shares?
As of February 08, 2026, the stock is trading at USD 159.17 with a total of 10,178,525 shares traded.
Over the past week, the price has changed by +4.88%, over one month by +14.57%, over three months by +9.70% and over the past year by -3.15%.
Over the past week, the price has changed by +4.88%, over one month by +14.57%, over three months by +9.70% and over the past year by -3.15%.
Is PG a buy, sell or hold?
Procter & Gamble has received a consensus analysts rating of 4.04.
Therefore, it is recommended to buy PG.
- StrongBuy: 11
- Buy: 5
- Hold: 8
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the PG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 167.5 | 5.2% |
| Analysts Target Price | 167.5 | 5.2% |
| ValueRay Target Price | 170.5 | 7.1% |
PG Fundamental Data Overview February 07, 2026
P/E Trailing = 23.5807
P/E Forward = 22.4215
P/S = 4.3695
P/B = 6.9741
P/EG = 4.7681
Revenue TTM = 85.26b USD
EBIT TTM = 15.84b USD
EBITDA TTM = 23.62b USD
Long Term Debt = 25.58b USD (from longTermDebt, last quarter)
Short Term Debt = 11.06b USD (from shortTermDebt, last quarter)
Debt = 36.64b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 25.81b USD (from netDebt column, last quarter)
Enterprise Value = 398.35b USD (372.54b + Debt 36.64b - CCE 10.82b)
Interest Coverage Ratio = 39.02 (Ebit TTM 15.84b / Interest Expense TTM 406.0m)
EV/FCF = 26.83x (Enterprise Value 398.35b / FCF TTM 14.85b)
FCF Yield = 3.73% (FCF TTM 14.85b / Enterprise Value 398.35b)
FCF Margin = 17.42% (FCF TTM 14.85b / Revenue TTM 85.26b)
Net Margin = 19.31% (Net Income TTM 16.47b / Revenue TTM 85.26b)
Gross Margin = 50.68% ((Revenue TTM 85.26b - Cost of Revenue TTM 42.05b) / Revenue TTM)
Gross Margin QoQ = 51.22% (prev 51.37%)
Tobins Q-Ratio = 3.13 (Enterprise Value 398.35b / Total Assets 127.29b)
Interest Expense / Debt = -0.60% (Interest Expense -220.0m / Debt 36.64b)
Taxrate = 20.11% (1.09b / 5.42b)
NOPAT = 12.66b (EBIT 15.84b * (1 - 20.11%))
Current Ratio = 0.72 (Total Current Assets 26.59b / Total Current Liabilities 36.70b)
Debt / Equity = 0.69 (Debt 36.64b / totalStockholderEquity, last quarter 53.32b)
Debt / EBITDA = 1.09 (Net Debt 25.81b / EBITDA 23.62b)
Debt / FCF = 1.74 (Net Debt 25.81b / FCF TTM 14.85b)
Total Stockholder Equity = 52.72b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.18% (Net Income 16.47b / Total Assets 127.29b)
RoE = 31.23% (Net Income TTM 16.47b / Total Stockholder Equity 52.72b)
RoCE = 20.23% (EBIT 15.84b / Capital Employed (Equity 52.72b + L.T.Debt 25.58b))
RoIC = 14.52% (NOPAT 12.66b / Invested Capital 87.18b)
WACC = 5.77% (E(372.54b)/V(409.17b) * Re(6.39%) + D(36.64b)/V(409.17b) * Rd(-0.60%) * (1-Tc(0.20)))
Discount Rate = 6.39% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.90%
[DCF Debug] Terminal Value 86.63% ; FCFF base≈15.59b ; Y1≈16.06b ; Y5≈18.05b
Fair Price DCF = 218.6 (EV 536.59b - Net Debt 25.81b = Equity 510.78b / Shares 2.34b; r=5.90% [WACC]; 5y FCF grow 3.03% → 2.90% )
EPS Correlation: 60.78 | EPS CAGR: 8.08% | SUE: -1.06 | # QB: 0
Revenue Correlation: 63.40 | Revenue CAGR: 3.70% | SUE: -0.34 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.57 | Chg30d=-0.021 | Revisions Net=-13 | Analysts=17
EPS current Year (2026-06-30): EPS=6.97 | Chg30d=-0.032 | Revisions Net=-7 | Growth EPS=+2.0% | Growth Revenue=+2.8%
EPS next Year (2027-06-30): EPS=7.32 | Chg30d=-0.032 | Revisions Net=-6 | Growth EPS=+5.0% | Growth Revenue=+2.8%
P/E Forward = 22.4215
P/S = 4.3695
P/B = 6.9741
P/EG = 4.7681
Revenue TTM = 85.26b USD
EBIT TTM = 15.84b USD
EBITDA TTM = 23.62b USD
Long Term Debt = 25.58b USD (from longTermDebt, last quarter)
Short Term Debt = 11.06b USD (from shortTermDebt, last quarter)
Debt = 36.64b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 25.81b USD (from netDebt column, last quarter)
Enterprise Value = 398.35b USD (372.54b + Debt 36.64b - CCE 10.82b)
Interest Coverage Ratio = 39.02 (Ebit TTM 15.84b / Interest Expense TTM 406.0m)
EV/FCF = 26.83x (Enterprise Value 398.35b / FCF TTM 14.85b)
FCF Yield = 3.73% (FCF TTM 14.85b / Enterprise Value 398.35b)
FCF Margin = 17.42% (FCF TTM 14.85b / Revenue TTM 85.26b)
Net Margin = 19.31% (Net Income TTM 16.47b / Revenue TTM 85.26b)
Gross Margin = 50.68% ((Revenue TTM 85.26b - Cost of Revenue TTM 42.05b) / Revenue TTM)
Gross Margin QoQ = 51.22% (prev 51.37%)
Tobins Q-Ratio = 3.13 (Enterprise Value 398.35b / Total Assets 127.29b)
Interest Expense / Debt = -0.60% (Interest Expense -220.0m / Debt 36.64b)
Taxrate = 20.11% (1.09b / 5.42b)
NOPAT = 12.66b (EBIT 15.84b * (1 - 20.11%))
Current Ratio = 0.72 (Total Current Assets 26.59b / Total Current Liabilities 36.70b)
Debt / Equity = 0.69 (Debt 36.64b / totalStockholderEquity, last quarter 53.32b)
Debt / EBITDA = 1.09 (Net Debt 25.81b / EBITDA 23.62b)
Debt / FCF = 1.74 (Net Debt 25.81b / FCF TTM 14.85b)
Total Stockholder Equity = 52.72b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.18% (Net Income 16.47b / Total Assets 127.29b)
RoE = 31.23% (Net Income TTM 16.47b / Total Stockholder Equity 52.72b)
RoCE = 20.23% (EBIT 15.84b / Capital Employed (Equity 52.72b + L.T.Debt 25.58b))
RoIC = 14.52% (NOPAT 12.66b / Invested Capital 87.18b)
WACC = 5.77% (E(372.54b)/V(409.17b) * Re(6.39%) + D(36.64b)/V(409.17b) * Rd(-0.60%) * (1-Tc(0.20)))
Discount Rate = 6.39% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.90%
[DCF Debug] Terminal Value 86.63% ; FCFF base≈15.59b ; Y1≈16.06b ; Y5≈18.05b
Fair Price DCF = 218.6 (EV 536.59b - Net Debt 25.81b = Equity 510.78b / Shares 2.34b; r=5.90% [WACC]; 5y FCF grow 3.03% → 2.90% )
EPS Correlation: 60.78 | EPS CAGR: 8.08% | SUE: -1.06 | # QB: 0
Revenue Correlation: 63.40 | Revenue CAGR: 3.70% | SUE: -0.34 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.57 | Chg30d=-0.021 | Revisions Net=-13 | Analysts=17
EPS current Year (2026-06-30): EPS=6.97 | Chg30d=-0.032 | Revisions Net=-7 | Growth EPS=+2.0% | Growth Revenue=+2.8%
EPS next Year (2027-06-30): EPS=7.32 | Chg30d=-0.032 | Revisions Net=-6 | Growth EPS=+5.0% | Growth Revenue=+2.8%